Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature
- PMID: 20233910
- DOI: 10.1345/aph.1M579
Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature
Abstract
Objective: To report 3 cases of immediate hypersensitivity reactions to moxifloxacin in patients who tolerated ciprofloxacin.
Case summaries: A 71-year-old man, a 44-year-old woman, and a 70-year-old woman with a history of a moxifloxacin reaction developed an immediate hypersensitivity reaction upon oral challenge with moxifloxacin in our Drug Safety Clinic. The reaction was mainly characterized by pruritus and urticaria, although dyspnea and hypotension were noted in the first and second patient, respectively. Two of the patients had negative oral challenge tests with ciprofloxacin and all 3 patients tolerated full treatment courses of oral ciprofloxacin. In all 3 cases, use of the Naranjo probability scale indicated a highly probable adverse drug reaction.
Discussion: Moxifloxacin, similar to other fluoroquinolones, can cause immediate hypersensitivity reactions. Previous publications have reported both cross-reactivity and a lack of cross-reactivity among various fluoroquinolones. The 3 patients discussed demonstrated a lack of cross-reactivity between moxifloxacin and ciprofloxacin since they tolerated oral challenge tests and full treatment courses of ciprofloxacin. Moxifloxacin has unique side chains at positions 7 and 8 on its bicyclic ring structure. Antigenic specificity to particular side chains at positions 7 and 8 on the bicyclic ring structure of moxifloxacin may explain this lack of cross-reactivity. Higher reporting rates of anaphylaxis to moxifloxacin compared to other fluoroquinolones may also be related to side chain specificity, although definitive evidence for this is lacking.
Conclusions: Based on our experience, patients who develop immediate hypersensitivity reactions to moxifloxacin may receive ciprofloxacin therapy in an appropriately monitored setting if they have previously tolerated full treatment courses of ciprofloxacin. Research into whether there is a specific side chain reaction unique to moxifloxacin is warranted.
Similar articles
-
Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity.J Investig Allergol Clin Immunol. 2005;15(2):146-9. J Investig Allergol Clin Immunol. 2005. PMID: 16047716
-
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.Curr Med Res Opin. 2007 Jun;23(6):1403-13. doi: 10.1185/030079907X188099. Epub 2007 May 8. Curr Med Res Opin. 2007. PMID: 17559736 Review.
-
Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.J Drugs Dermatol. 2008 Aug;7(8):794-5. J Drugs Dermatol. 2008. PMID: 18720700
-
Moxifloxacin and torsade de pointes.Ann Pharmacother. 2007 Feb;41(2):336-40. doi: 10.1345/aph.1H474. Epub 2007 Feb 6. Ann Pharmacother. 2007. PMID: 17284508
-
Evaluation of immediate allergic reactions to cephalosporins in non-penicillin-allergic patients.Int Arch Allergy Immunol. 2009;150(3):205-9. doi: 10.1159/000222672. Epub 2009 Jun 3. Int Arch Allergy Immunol. 2009. PMID: 19494517 Review.
Cited by
-
Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic.J Allergy Clin Immunol Pract. 2021 Feb;9(2):1024-1028.e3. doi: 10.1016/j.jaip.2020.09.017. Epub 2020 Sep 24. J Allergy Clin Immunol Pract. 2021. PMID: 32980582 Free PMC article. No abstract available.
-
Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.Clin Rev Allergy Immunol. 2022 Jun;62(3):505-518. doi: 10.1007/s12016-021-08919-5. Epub 2022 Jan 29. Clin Rev Allergy Immunol. 2022. PMID: 35092578 Free PMC article. Review.
-
Usefulness of In Vivo and In Vitro Diagnostic Tests in the Diagnosis of Hypersensitivity Reactions to Quinolones and in the Evaluation of Cross-Reactivity: A Comprehensive Study Including the Latest Quinolone Gemifloxacin.Allergy Asthma Immunol Res. 2017 Jul;9(4):347-359. doi: 10.4168/aair.2017.9.4.347. Allergy Asthma Immunol Res. 2017. PMID: 28497922 Free PMC article.
-
Update on Quinolone Allergy.Curr Allergy Asthma Rep. 2017 Aug;17(8):56. doi: 10.1007/s11882-017-0725-y. Curr Allergy Asthma Rep. 2017. PMID: 28752367 Review.
-
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1099-106. doi: 10.1002/pds.3499. Epub 2013 Aug 20. Pharmacoepidemiol Drug Saf. 2013. PMID: 23963962 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical